Department of General and Specialized Surgery, Faculty of Medicine, the Hashemite University, Zarqa, 13133, Jordan.
Department of General and Endocrine Surgery, University of Poitiers, CHU Poitiers, Poitiers, France.
Endocrine. 2021 Dec;74(3):611-615. doi: 10.1007/s12020-021-02788-w. Epub 2021 Jun 10.
Recent clinical practice guidelines consider thyroid lobectomy a viable alternative for low-risk papillary thyroid carcinoma PTC measuring 1-4 cm in size. We aimed to assess the likelihood of finding postoperatively determined high-risk histopathologic features that would lead to the recommendation of completion thyroidectomy.
A retrospective review of patients who underwent total thyroidectomy for PTC measuring 1-4 cm in size between Jan 2012 and Jan 2018 was conducted. Patients with pre-operative high-risk characteristics were excluded: history of radiation exposure, positive family history, clinically suspicious cervical lymphadenopathy, and gross extrathyroidal extension (ETE). A hypothetical group of 245 patients remained eligible for lobectomy. The pathology specimens from the cancer-containing lobes were evaluated for high-risk features: aggressive histology, capsular and/or vascular invasion, microscopic ETE, and multifocality. A subgroup analysis was performed with 2 cm being the cut-off size.
The average age was 39 years with 73% being females. Mean cancer size was 16 mm. Evaluation of the cancer-containing lobe for high-risk features revealed: aggressive histology (33%), ETE (12%), capsular invasion (33%), vascular invasion (17%), and ipsilateral multifocality (30%). The cumulative risk of having ≥1 high-risk feature mandating completion thyroidectomy was 59%. The risk was considerably higher for lesions ≤2 cm compared to larger lesions (64% vs.48%; p = 0.049; RR = 1.3).
A considerable proportion of patients initially eligible for lobectomy have high-risk features that only become evident at pathology. Therefore, a comprehensive approach is advocated to determine the extent of surgery for PTC incorporating patient preferences regarding risks and benefits.
最近的临床实践指南认为,对于 1-4cm 大小的低危甲状腺乳头状癌(PTC),甲状腺叶切除术是一种可行的替代方案。我们旨在评估术后确定的高危组织病理学特征的可能性,这些特征将导致推荐行甲状腺全切除术。
对 2012 年 1 月至 2018 年 1 月期间行甲状腺全切除术治疗 1-4cm 大小的 PTC 的患者进行回顾性研究。排除术前具有高危特征的患者:辐射暴露史、阳性家族史、临床可疑的颈部淋巴结肿大和大体甲状腺外侵犯(ETE)。有 245 例患者符合行甲状腺叶切除术的条件。评估含癌叶的病理标本是否存在高危特征:侵袭性组织学、包膜和/或血管侵犯、镜下 ETE 和多灶性。以 2cm 为截点进行亚组分析。
患者平均年龄为 39 岁,女性占 73%。平均癌症大小为 16mm。评估含癌叶的高危特征发现:侵袭性组织学(33%)、ETE(12%)、包膜侵犯(33%)、血管侵犯(17%)和同侧多灶性(30%)。需要行甲状腺全切除术以治疗至少 1 个高危特征的累积风险为 59%。≤2cm 的病变与较大病变相比,具有高危特征的风险更高(64% vs. 48%;p=0.049;RR=1.3)。
相当一部分最初符合甲状腺叶切除术条件的患者具有高危特征,这些特征仅在病理检查时才变得明显。因此,提倡采用综合方法来确定甲状腺癌手术范围,综合考虑患者对风险和获益的偏好。